Roche Pharmaceuticals A/S: Financial statements 2015
CVR: 25230515
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
Roche Pharmaceuticals A/S (CVR 25230515) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 893,694,000 and a net result of DKK 29,179,000 compared with DKK 26,654,000 the year before. That is an increase of 6.4% compared with the year before. The profit margin was 3.3%. Equity in the 2015 report amounted to DKK 129,405,000. The solvency ratio was 41%. The company had 111 employees in the financial year.
- Revenue
- DKK 893,694,000
- Gross Profit
- DKK 161,134,000
- Profit/Loss
- DKK 29,179,000
- Equity
- DKK 129,405,000
- Total Assets
- DKK 315,590,000
- Employees
- 111
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 893.7 mio. | 161.1 mio. | 29.2 mio. | 129.4 mio. | 111 |
| 2014 | 839.9 mio. | 144.3 mio. | 26.7 mio. | 100.2 mio. | 103 |
| 2013 | 689.8 mio. | 128.9 mio. | 14.5 mio. | 88.6 mio. | 103 |
Official annual report
How creditworthy is Roche Pharmaceuticals A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
Roche Pharmaceuticals A/S has published its annual report for 2014. Revenue came to DKK 839,936,000, and the net result was DKK 26,654,000.
As of February 11, 2015, is registered as an owner of Roche Pharmaceuticals A/S with an ownership share of 100%.
About Roche Pharmaceuticals A/S
Roche Pharmaceuticals A/S is a Danish company of the type Aktieselskab based in København V, founded in 1970. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ROCHE A/S. MEDICINALVARER & KEMIKALIER. The management consists of Carole Hassoun. The board consists of Isabel Marianne Joerin (chair), Carole Hassoun and Ehab Abdelmoneim Youssef Hassan. The company is owned by Roche Holding AG. The company has 96 employees (2026). In 2025, the company reported revenue of DKK 928,824,000 and a net result of DKK 31,319,000 compared with DKK 24,277,000 the year before. Equity in the 2025 report amounted to DKK 195,179,000.